Gainers
- MyMD Pharmaceuticals MYMD shares increased by 9.3% to $0.15 during Thursday's after-market session. The market value of their outstanding shares is at $7.8 million.
- PaxMedica PXMD shares rose 8.58% to $0.54. The company's market cap stands at $2.4 million.
- Oragenics OGEN shares moved upwards by 6.98% to $2.45. The market value of their outstanding shares is at $7.5 million.
- Lineage Cell Therapeutics LCTX shares moved upwards by 6.62% to $0.92. The market value of their outstanding shares is at $160.9 million.
- BioRestorative Therapies BRTX shares rose 6.01% to $2.29. The market value of their outstanding shares is at $10.7 million.
- Codexis CDXS shares rose 5.81% to $2.91. The market value of their outstanding shares is at $203.2 million.
Losers
- Kiora Pharmaceuticals KPRX stock declined by 10.6% to $0.76 during Thursday's after-market session. The company's market cap stands at $5.8 million.
- Cingulate CING shares fell 7.74% to $3.1. The market value of their outstanding shares is at $4.4 million.
- Adagene ADAG shares fell 7.5% to $3.33. The company's market cap stands at $145.9 million.
- Sharps Technology STSS shares declined by 7.1% to $0.38. The market value of their outstanding shares is at $5.8 million.
- Alzamend Neuro ALZN shares fell 7.03% to $0.81. The company's market cap stands at $5.3 million.
- Redhill Biopharma RDHL shares fell 6.48% to $0.56. The market value of their outstanding shares is at $16.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ALZNAlzamend Neuro Inc
$1.10-4.30%
BRTXBioRestorative Therapies Inc
$2.452.51%
CDXSCodexis Inc
$4.30-4.44%
CINGCingulate Inc
$4.570.44%
KPRXKiora Pharmaceuticals Inc
$3.99-%
LCTXLineage Cell Therapeutics Inc
$0.62990.54%
OGENOragenics Inc
--%
PXMDPaxMedica Inc
$0.360336029900.0%
RDHLRedhill Biopharma Ltd
$6.509.61%
STSSSharps Technology Inc
$0.4000-1.23%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in